Objective: To characterize [
Genetics, pathological studies, and biofluid markers involve neuroinflammation and specifically activated microglia in ALS pathophysiology. [1] [2] [3] Activated microglia are increased in ALS postmortem motor cortex, brainstem, and spinal cord tissue, and this increase correlates with faster disease progression. 4 Activated microglia are also detected near motor neurons of SOD1 G93A transgenic mice before the onset of weakness, and the inflammatory response in these mice correlates with disease progression. 5 Furthermore, lowering mutant SOD1 expression in microglia alone in Lox-SOD1 G37R mice prolongs survival, mostly due to slowing later disease progression. 3 We have previously shown increased [
11 C]-PBR28 uptake in the precentral gyrus in a small cohort of ALS participants compared to healthy controls (HCs). 6, 7 [
11 C]-PBR28 is a positron emission tomography (PET) radiotracer that binds to a 18pkD translocator protein (TSPO), 8 which is expressed in activated microglia, reactive astrocytes, vascular endothelium, and to a much lower degree in neurons. 9, 10 In this study, we will refer to activated microglia and astrocytes collectively as "glial activation." Here, we confirm our initial finding, correlate molecular (PET) and structural (magnetic resonance imaging [MRI]) measures with clinical outcomes, and study the longitudinal changes of [
C]-PBR28 in a cohort of patients with ALS and primary lateral sclerosis (PLS).

Subjects and Methods
Study Participants
This cross-sectional and longitudinal study was conducted at Massachusetts General Hospital (MGH). Between May 22, 2012 and May 24, 2017 , 85 individuals including 53 with ALS, 11 with PLS, and 21 HCs were recruited from the ALS clinic at MGH and from online advertisements for healthy volunteers. The eligibility criteria included having either mixed or high TSPO binding affinity, 11 not taking any antiinflammatory, immunomodulating, or experimental therapies, and having no contraindication for PET-MRI scan. In addition, ALS participants needed to satisfy the modified El Escorial diagnostic criteria, 12 and PLS participants needed to fulfill the Pringles diagnostic criterion 13 of having progressive pure upper motor neuron (UMN) dysfunction for at least 4 years. All study participants were genotyped for the TSPO gene Ala147Thr polymorphism, which predicts binding affinity to [ 11 C]-PBR28. 14 Depending on this genotype, subjects can either be high (ala/ala), mixed (ala/thr), or low (thr/thr) affinity binders. Because the PET signal in low affinity binders is negligible, participants with the (thr/thr) genotype were excluded from the study. High or mixed affinity binder status was modeled as a regressor of no interest in all the analyses to account for differences in PET signal across genotypes. Participants who fulfilled the inclusion/exclusion criteria and were either mixed or high TSPO binders underwent [ 11 C]-PBR28 PET and MRI at the Martinos Center for Biomedical Imaging at MGH (Boston, MA). In addition, ALS and PLS participants were evaluated clinically using the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) 15 and the Upper Motor Neuron Burden (UMNB) scale. 6 The rate of disease progression at baseline was calculated as [(48 minus baseline total ALSFRS-R)/disease duration]. This study was approved by the Partners Institutional Review Board, and the MGH Radioactive Drug Research Committee. All participants provided written informed consent before study enrollment.
PET-MRI Data Acquisition
All participants underwent imaging studies using the same integrated PET-MRI scanner, which consisted of a 3T Magnetom Tim Trio scanner (Siemens, Erlangen, Germany) with a PET insert. 17 and PET data were quantified as standardized uptake value (SUV). To account for the large interindividual variability in the global PET signal, SUV was normalized by whole brain PET uptake and expressed as SUV ratio (SUVR). 7 The primary MRI measures were FreeSurfer (v6.0, https://surfer.nmr.mgh.harvard.edu/) derived cortical thickness, and diffusion parameters (fractional anisotropy and mean diffusivity) to evaluate brain structural integrity. The preprocessing steps of the raw diffusion data were performed using FMRIB Software Library FSL (v5.0.9, https://fsl.fmrib.ox.ac.uk/fsl/ fslwiki/) and included motion and quality evaluations. These steps have been previously described in detail. 18 In addition, diffusion data were corrected for eddy current-induced distortions and subject movements. 19 Fractional anisotropy and mean diffusivity maps were obtained by fitting a diffusion tensor model at each voxel using the FSL-FDT toolbox. PET-MRI data were analyzed using the following methods: (1) whole brain voxelwise analyses, (2) whole brain surface-based analyses, 20 and (3) regions of interest (ROIs).
FreeSurfer v6.0 tools were employed to create 3 composite ROIs. Anatomically, the ROIs included the precentral and paracentral gyri bilaterally. The first ROI is for the gray matter. The second ROI is for the subcortical white matter. The third ROI is combined for both gray and white matter. The first and second ROIs were used to study the difference in PET-MRI measures between the study groups. The third ROI was used to conduct Pearson correlation analyses between [ 11 C]-PBR28, MRI measures, and the clinical data. Specifically, the T1 images were analyzed using FreeSurfer's "recon-all" fully automated pipeline. The output from this processing stream included atlases for cortical and subcortical regions. The processed output data were carefully reviewed for quality assurance. FreeSurfer tools were used to create 3 ROIs for every subject as clarified above. Finally, PET-MRI measures were computed within these ROIs.
In a separate analysis, the same 3 ROIs were created by processing the standard template MNI152-2mm in FreeSurfer v6.0 using the same steps as above. The purpose of this analysis is to compute PET-MRI measures from images in the standard space (ie, from the same images used in the voxelwise analyses). This analysis was employed specifically to confirm that brain atrophy had no impact on the registration of the PET images.
Statistical Analyses
WHOLE BRAIN VOXELWISE ANALYSES. Nonparametric permutation inference 21 of SUVR data was performed by FSL v5.0.9 and used to study voxelwise [ 11 C]-PBR28 uptake differences between the groups. General linear model (GLM) was used in the whole brain voxelwise analyses to adjust for the effect of age, sex, and [ 11 C]-PBR28 binding affinity. Multicollinearity in these analyses was avoided by a stepwise (forward addition and backward elimination) selection of covariates.
SURFACE-BASED ANALYSES. The surface-based analyses of cortical thickness and SUVR were performed in FreeSurfer v6.0 using the same pipeline. Specifically, both data were smoothed similarly using a full width at half maximum of 6mm, resampled onto the brain surfaces, and clusterwise corrected for multiple comparisons using Monte Carlo simulation. The analyses were set to keep clusters that have clusterwise p value (p cw ) < 0.01, and the voxelwise/cluster forming threshold was Z 5 3 (p < 0.001).
GLM was used in the whole brain surface-based analyses to adjust: (1) cortical thickness data for the effect of age and sex; and (2) SUVR data for the effect of age, sex, and binding affinity; multicollinearity was avoided as previously clarified. Partial volume correction (PVC) for SUVR maps was performed in FreeSurfer v6.0 based on Muller-Gartner method. 22 The recommended stream according to published data 23 is to feed these corrected SUVR maps into 3 group-level analyses:
(1) surface-based for the left hemisphere, (2) surface-based for the right hemisphere, and (3) volumetric analysis for subcortical gray matter using the mask for this region automatically defined by FreeSurfer v6.0.
WHOLE BRAIN VOXELWISE CORRELATION ANALYSES. WWhole brain voxelwise correlation analyses were conducted to study the relationship between PET data and the clinical measures of UMNB and ALSFRS-R. Furthermore, fractional anisotropy was measured in 42 ALS participants within a combined ROI that include the gray matter and the underlying subcortical white matter of the precentral and paracentral gyri bilaterally, and then fed into a voxelwise correlation analysis to investigate areas of correlation between fractional anisotropy and whole brain PET signal. In all whole brain voxelwise analyses, data were permuted (n 5 10,000), threshold free cluster enhancement method was applied, 24 and the p values were familywise error adjusted (p FWE ), 25 using an alpha value of p 5 0.05 to correct for multiple comparisons. All the voxelwise analyses were adjusted for the number of contrasts used in these analyses. PBR28 at the baseline and after 6 months were performed using JMP pro v13.0.0 (SAS Institute, Cary, NC). Nonparametric comparison for each pair was applied using the Wilcoxon test. Bonferroni method was used to correct for multiple tests.
PAIRED T TEST, SAMPLE SIZES, AND POWER ANALYSES. -
Based on the available longitudinal data of the 10 ALS participants, we performed sample size and power calculations for a potential future single-arm clinical trial that implements [
11 C]-PBR28 as an outcome measure. The goal of this proposed trial is to compare the change in [ 11 C]-PBR28 uptake in an ROI that includes the precentral and paracentral gyri bilaterally between before and after 6 months of an experimental treatment.
To estimate the required sample size, we measured the difference in [ 11 C]-PBR28 at the baseline and after 6 months for each of the 10 participants who completed the 6-month follow up scan. We then estimated the SD of the 6-month [ 11 C]-PBR28 change for these participants and used a paired t test sample size calculation with a power of 80% and an alpha of 0.05. Table 1 shows the demographic and clinical characteristics of all 85 study participants including ALS (n 5 53), PLS (n 5 11), and controls (n 5 21).
Results
Demographics and Clinical Data Findings
Whole Brain Voxelwise Analyses
These analyses revealed increased There were no regions that showed a difference in [
11 C]-PBR28 uptake between the groups in the other direction (ie, HCs > ALS, HCs > PLS, or ALS > PLS).
Surface-Based Analyses
The surface-based analyses with and without PVC confirmed that ALS participants have higher No difference in [
11 C]-PBR28 uptake was detected between ALS and PLS on the cortical surfaces (see Fig  2D; p cw 5 0.01), whereas cortical thickness was reduced in PLS compared to ALS (see Fig 2E; Fig 3) . The voxelwise correlation analysis between [ 11 C]-PBR28 uptake and fractional anisotropy was conducted in 42 ALS participants, because 11 ALS diffusion scans were excluded from the analyses due to motion artifacts.
ROI Analyses
Pearson correlation analyses of [ The correlation between cortical thickness and [ 11 C]-PBR28 uptake was performed in the gray matter ROI, and it showed a negative relationship (r 5 20.49, p 5 0.0002; Fig 4) .
To study the distribution of [ 11 C]-PBR28 uptake between the gray matter and subcortical white matter for each group (ie, ALS, PLS, and HCs), PET signal was computed within the gray matter ROI and the subcortical white matter ROI for each participant. In the gray matter ROI, [ 11 C]-PBR28 uptake was 0.0462 (4.6%) higher in ALS (p 5 0.0012) and 0.036 (3.6%) higher in PLS (p 5 0.12) compared to controls, and the gray matter uptake was only 0.011 (1.1%) higher in ALS compared to PLS (p 5 0.65; Fig 5A) . In the subcortical white matter ROI, [ 11 C]-PBR28 uptake was 0.075 (7.5%) higher in ALS (p < 0.0001) and 0.136 (13.6%) higher in PLS (p < 0.0001) compared to controls. The uptake was 0.059 (5.9%) higher in PLS compared to ALS (p 5 0.035; see Fig 5B) . The correlation between [ 11 C]-PBR28 uptake measured within ROIs in the native space and [
11 C]-PBR28 uptake computed within ROIs in the standard space was r 5 0.96, p < 0.0001. This correlation confirms that the registration method had no effect on the computed PET signal. The final results presented in Table 2 are reported from ROIs derived from the standard space.
Comparing diffusion measures in the gray and white matter ROIs between the study groups revealed decreased fractional anisotropy and increased mean diffusivity in ALS compared to HCs, in PLS compared to HCs, and in PLS compared to ALS (all p < 0.05; see Fig   5) . Comparisons in the gray and white matter portions of fractional anisotropy and mean diffusivity between the groups are summarized in Table 2 C]-PBR28 uptake in any brain region over 6 months in ALS participants. Similarly, fractional anisotropy (r 5 0.95, p < 0.0001) and cortical thickness (r 5 0.84, p 5 0.0023) were strongly correlated between the visits despite disease progression measured by a change in mean 6 SD ALSFRS-R (baseline 39.6 6 3.8, 6 months 36.6 6 4.6), which corresponds to an ALSFRS-R rate of decline of 0.5 points/mo (Fig 6) . The regions of interest were derived from a FreeSurfer cortical reconstruction of the standard template MNI152-2mm. The box plots (blue, controls; orange, ALS; green, PLS) illustrate the difference between the groups in [
11 C]-PBR28 uptake, and mean diffusivity in the gray matter portions of the precentral and paracentral gyri (A) and [ 11 C]-PBR28 uptake, fractional anisotropy, and mean diffusivity in the white matter portions for the same regions (B). The horizontal black line within each box plot represents the median (the box contains median, 25th, and 75th percentiles). The dashed zero line is the mean of the 3 groups. The results of these comparisons between the groups are derived from a nonparametric Wilcoxon method for each pair. The significant difference between groups was set at p 5 0.05 (*Bonferroni adjusted p 5 0.05/6 5 0.0083). Z scores were generated to improve visualization and standardize the scales. PET-MR 5 positron emission tomographic magnetic resonance.
The mean 6 SD change between baseline and 6 months in [ 
Discussion
We followed an integrated [ 11 C]-PBR28 PET-MRI approach to characterize brain glial activation and its relationship with structural changes in people with ALS and PLS.
These current data confirm our earlier findings of elevated [ 11 C]-PBR28 uptake in the motor cortices and subcortical white matter in people with ALS. 6, 7 The increased glial activation measured by [ 11 C]-PBR28 PET is seen in the same anatomical regions where we see cortical thinning and subcortical reduction in fractional anisotropy measured by MRI. All together, these molecular and structural imaging findings mirror the postmortem pathological changes of atrophy and increased active astrocytes and microglia in the cortical motor regions in ALS. In addition, [ 11 C]-PBR28 uptake is increased in the temporal lobe without cortical thinning (see Fig 2A) . This could represent subclinical changes related to known association between ALS and frontotemporal dementia, may be related to early [ 11 C]-PBR28 uptake preceding atrophy in the temporal lobe, or could be due to different sensitivity levels between [ 26, 27 Compared to these earlier efforts, the current study enrolled, prominently, a larger number of participants (53 ALS, 11 PLS, and 21 HCs) with longitudinal data collected from 10 ALS participants, and direct MRI and clinical correlates. In contrast, none of the previous studies included longitudinal data and the sample sizes were smaller, consisting of roughly 10 ALS participants. In addition, the findings of decreased fractional anisotropy and increased mean diffusivity in ALS and PLS compared to HCs were consistent with prior reports. 28, 29 These diffusion changes probably represent the loss of gray and white matter integrity in the motor regions in ALS and PLS. Mean diffusivity measures were used to evaluate gray matter integrity in other neurodegenerative diseases.
30-34
The diffusion results (ie, increased diffusivity and decreased fractional anisotropy) are indicators of the neuronal damage seen in ALS and PLS. However, more interesting is the negative relationship between fractional anisotropy and [
11 C]-PBR28 uptake in the whole brain voxelwise correlation analysis. This relationship suggests that the neuronal damage in ALS and PLS may be caused directly by the inflammatory products of the activated glial cells, or conversely, the injured tissues may be the trigger of glial activation. ]-PBR28 uptake is normal presymptomatically then increases at some point before, or at the time of symptom onset. The longitudinal data demonstrate that [ 11 C]-PBR28 uptake is relatively stable over 6 months, which could suggest that the uptake may plateau shortly after symptom onset. This pattern mirrors amyloid beta changes measured by Pittsburg compound B PET showing a steep increase at the time of mild cognitive impairment followed by a plateau when patients develop clinical Alzheimer disease (AD). 34 Unlike amyloid beta uptake, the longitudinal changes of [ 11 C]-PBR28 uptake correlate with AD progression after a median follow-up of 2.7 years, 35 and similar findings could be expected in ALS with a shorter follow-up. In our data, the stability of [ 11 C]-PBR28 uptake over 6 months could be the result of biased selection of people with a slow ALS progression rate (0.5 points/mo), and this is almost 50% slower than the average in ALS clinical trials. The selection of slow progressors may have obscured an increase in [ 11 C]-PBR28 over 6 months. Larger longitudinal studies that enroll people with faster disease progression are needed to fully answer this question.
We The strengths of this study are the inclusion of a large number of participants, the use of an advanced integrated PET-MRI scanner, and the implementation of fully automated neuroimaging processing pipelines that can be scaled up and used at other imaging centers. This study, however, has several limitations. One limitation is that a priori sample size calculation was not conducted, and we consider these results as exploratory. Another limitation is that [ 11 C]-PBR28 does not distinguish microglia from astrocytes or differentiate different microglial phenotypes. This study did not correct diffusion data (specifically mean diffusivity) for partial volume effects. However, there is still no optimal approach that can be applied. In this regard, our study and all prior studies published in the literature [36] [37] [38] are considered preliminary.
In this study, we elected to quantify [ 11 C]-PBR28 PET signal using a simplified ratio metric (SUVR), instead of performing full kinetic modeling using radio metabolite-corrected arterial input function modeling. The SUVR approach is less invasive but more scalable to multiple center studies. Our previous work suggests that SUVR and volume of distribution, computed using metabolite-corrected input function, have similar sensitivity to detect group differences between ALS and healthy volunteers. 39 In addition, prior published data have
shown that it has moderate to high reliability, and it has comparable agreement with full kinetic modeling approaches. 40 However, although semiquantitative methods have several advantages, they are not immune from criticisms 41 and are not considered gold standard. 
